Does Dr. YOUSEF ABU-SALHA have financial conflicts of interest?

Dr. YOUSEF ABU-SALHA (MD) has received a total of $473 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $473 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. YOUSEF ABU-SALHA?

According to CMS Open Payments data, Dr. YOUSEF ABU-SALHA received funding from DENDREON PHARMACEUTICALS ($128), SUMITOMO PHARMA AMERICA ($103), and PROGENICS PHARMACEUTICALS ($44).

Does Dr. YOUSEF ABU-SALHA receive research grants or speaking fees?

Dr. YOUSEF ABU-SALHA has received $473 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. YOUSEF ABU-SALHA

MDReal-Time Hydrated

Specialty: Urology

Practice Location: CARY, NC 27518

NPI Number: 1336704220

LIFETIME INDUSTRY VALUE

$473

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABU-SALHA is a verified Urology practitioner based in CARY, NC.

Between 2021 and 2024, Dr. ABU-SALHA had an overall industry promotional and research financial footprint of $473 as recorded in the federal CMS Open Payments database.

$473 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABU-SALHA's primary funding source is DENDREON PHARMACEUTICALS, which accounts for $128 (representing 27.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

DENDREON PHARMACEUTICALS

Rank 1

$128

27.2%

SUMITOMO PHARMA AMERICA

Rank 2

$103

21.7%

PROGENICS PHARMACEUTICALS

Rank 3

$44

9.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.